IFRX · InflaRx N.V.
$1.73
-0.07 (-3.89%)
At close · Jul 23
Market Cap
$254.82M
Shares
147.29M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.73
Open$1.79
Day$1.72–1.83
52W$0.74–2.95
Avg vol 30d1.2M
Short int8.1M · 5.5% float · 4.9d
Short vol48%
DataJan 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+23%
above
Price vs 50-day avg
−17%
below
RSI (14)
36
neutral
MACD trend
Negative
52-week position
45%
mid-range
Momentum
relative strength
1-month return
−10%
trailing
6-month return
+87%
trailing
YTD return
+71%
this year
Relative strength
+81%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $1 — 50d above 200d
Institutional flow
Flat
1 of 36 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
5.51% of float · ▲ +16.7% MoM · 4.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
36 holders — mid 3-yr range
Squeeze score
64
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
109%
annualized · 1-yr
Max drawdown
−53%
past year
ATR
10.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+23%
Bullish
Price vs 50-day avg
−17%
Bearish
RSI (14)
36
Neutral
MACD trend
Negative
Bearish
52-week position
45%
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $2 › 200d $1 — 50d above 200d
Institutional flow
Flat
1 of 36 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
5.51% of float · ▲ +16.7% MoM · 4.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
36 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $2 · 45%
52-wk high $3
vs 200-day avg +23%
vs 50-day avg -17%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IFRX
this stock
InflaRx N.V.
|
$254.82M | +71.3% | — | — | 5.5% |
|
ONC
BeOne Medicines Ltd.
|
$472.27B | +7.6% | +22179.2% | 961.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$120.07B | +4.4% | +46.2% | 28.1 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.35B | -15.4% | +20.8% | 15.9 | 3.3% |
|
ARGX
Argenx SE
|
$57.84B | +9.9% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IFRX | -9.4% | -10.4% | +87.4% | -22.8% | +71.3% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | -7.8% | -11.0% | +81.1% | -21.6% | +63.0% |